중심장액맥락망막병증의 레이저 치료 후 발생한 맥락막신생혈관 4예
Laser-Induced Choroidal Neovascularization in Central Serous Chorioretinopathy: 4 Cases
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적: 중심장액맥락망막병증의 레이저 치료 후 맥락막신생혈관이 발생한 증례들을 경험하여 문헌고찰과 함께 보고하고자 한다. 증례요약: 시력저하를 주소로 내원한 중심장액맥락망막병증 환자 4명(4안) 중 3명에서 레이저광응고술, 1명에서 광역학치료를 시행하였다. 치료 후 3명은 평균 1개월 후, 1명은 1년 3개월 후 치료 시행부위에서 맥락막신생혈관이 발생하였다. 맥락막신생혈관의 치료로3명에서 유리체강내 베바시주맙 주입술을 시행하였고, 1명에서는 아르곤레이저 광응고술을 시행하였다. 시력호전과 함께 병변은 치료되었으며 이후 안정된 상태를 유지하였다. 결론: 중심장액맥락망막병증에서 레이저 치료는 아직까지 좋은 효과를 보이는 치료방법이지만 이차적인 맥락막신생혈관 등의 합병증을 동반할 수 있어 주의를 요한다.
Abstract
Purpose: To report the choroidal neovascularization of 4 patients in central serous chorioretinopathy treated with laser treatment. Case summary: We reported 4 patients with central serous chorioretinopathy. Three patients were treated with focal laser photocoagulation, and 1 patient with photodynamic treatment. All patients newly developed choroidal neovascularization (CNV) after treatment at the area of laser treatment. Three patients received intravitreal anti-VEGF injection and 1 patient received argon laser photocoagulation for the treatment of CNV. After the treatment, the CNV was resolved with improved visual acuity. Conclusions: Laser treatment may be efficacious tool to achieve rapid resolution in central serous chorioretinopathy until now. However, more caution at the time of treatment and close follow-up after treatment are warranted.
참고문헌 (25)
- Gass JD, "Serous detachment of the retinal pigment epithelium", Trans Am Acad Ophthalmol Otolaryngol, 70, pp.990~1015 (1966)
- Yannuzzi LA, "Type-A behavior and central serous chorioretinopathy", Retina, 7, pp.111~131 (1987)
- Spaide RF, "Central serous chorioretinopathy in younger and older adults", Ophthalmology, 103, pp.2070~2079 (1996)
- Huang WC, "Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy", Eye (Lond), 23, pp.488~489 (2009)
- Niegel MF, "Intravitreal bevacizumab for chronic central serous chorioretinopathy", Ophthalmologe, 105, pp.943~945 (2008)
- Leaver P, "Argon Laser photocoagulation in the treatment of central serous retinopathy", Br J Ophthalmol, 63, pp.674~677 (1979)
- Novak MA, "Krypton and argon laser photocoagulation for central serous chorioretinopathy", Retina, 7, pp.162~169 (1987)
- Chan WM, "Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level", Br J Ophthalmol, 87, pp.1453~1458 (2003)
- Schatz H, "Subretinal neovascularization following argon laser photocoagulation treatment for central serouschorioretinopathy: complication or misdiagnosis?", Trans Sect Ophthalmol Am Acad OPhthalmol Otolaryngol, 83, pp.893~906 (1977)
- Watzke RC, "Direct and indirect laser photocoagulation of central serous choroidopathy", Am J Ophthalmol, 88, pp.914~918 (1979)
- Ha TW, "Management of choroidal neovascularization following laser photocoagulation for central serous chorioretinopathy", Korean J Ophthalmol, 16, pp.88~92 (2002)
- Watzke RC, "Ruby laser photocoagulation therapy of central serous retinopathy. I. A controlled clinical study. II. Factors affecting prognosis", Trans Am Acad Ophthalmol Otolaryngol, 78, pp.205~211 (1974)
- Klein ML, "Experience with nontreatment of central serous choroidopathy", Arch Ophthalmol, 91, pp.247~250 (1974)
- Bandello F, "ICG angiography and retinal pigment epithelial decompensation (CRSC and epitheliopathy)", J Fr Ophtalmol, 24, pp.448~451 (2001)
- Maumenee AE, "Macular diseases: clinical manifestations", Trans Am Acad Ophthalmol Otolaryngol, 69, pp.605~613 (1965)
- Spitznas M, "Pathogenesis of central serous retinopathy: a new working hypothesis", Graefes Arch Clin Exp Ophthalmol, 224, pp.321~324 (1986)
- Miller S, "Cyclic AMP modulation of ion transport across frog retinal pigment epithelium. Measurements in the short-circuit state", J Gen Physiol, 83, pp.853~874 (1984)
- Schlingemann RO, "Role of growth factors and the wound healing response in age-related macular degeneration", Graefes Arch Clin Exp Ophthalmol, 242, pp.91~101 (2004)
- Kliffen M, "Increased expression of angiogenic growth factors in age-related maculopathy", Br J Ophthalmol, 81, pp.154~162 (1997)
- Frank RN, "Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes", Am J Ophthalmol, 122, pp.393~403 (1996)
- Taban M, "Chronic central serous chorioretinopathy: Photodynamic therapy", Am J Ophthalmol, 137, pp.1073~1080 (2004)
- Canakis C, "Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy", Am J Ophthalmol, 136, pp.750~752 (2003)
- Schmidt-Erfurth U, "Histopathological changes following photodynamic therapy in human eyes", Arch Ophthalmol, 120, pp.835~844 (2002)
- Cardillo Piccolino F, "Photodynamic therapy for chronic central serous chorioretinopathy", Retina, 23, pp.752~763 (2003)
- Olivier S, "Photodynamic therapy for chronic serous detachment of the retinal pigment epithelium in a young patient", Can J Ophthalmol, 40, pp.214~216 (2005)